CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and Oophorectomy-Induced Osteoporosis via Modulating RANKL and ROS Signaling Pathways

Jing Li(Guangxi Medical University), Bo Zhou(Northwestern University)
Frontiers in Pharmacology
March 8, 2022
Cited by 24


Related Papers